The global Non Opioid Pain Relief Device Market is forecast to grow at a CAGR of 8.3% during the forecast period from 2023 to 2031. The global market is forecast to increase in revenue of reach US$ 10,311 million by 2031 from US$ 5,031 million in 2022.
The global non-opioid pain management devices market is witnessing significant growth possibilities during the forecast period. The aging global population that experiences chronic pain and the rising need for non-invasive, non-pharmacological pain management solutions are the major factors driving the market growth. Asia Pacific is predicted to become a rapidly expanding market owing to its sizable population, rising healthcare spending, and rising use of cutting-edge medical technology. The market future is promising with technological advancements focusing on intelligent, connected devices that offer tailored pain management.
A Request of this sample Report Here – https://www.astuteanalytica.com/request-sample/non-opioid-pain-relief-device-market
The global non-opioid pain treatment market is expanding as a result of an aging population and an increase in diseases like arthritis, cancer, epilepsy, dental disorders, etc., that cause chronic pain conditions. A growing global health concern is chronic pain, which affects over 1.5 billion individuals globally. This translates to a prevalence rate of more than 20% in the adult population. Among older adults, the number is even more startling, with around 50% reporting experiencing chronic pain.
The constricting regulations on the use of opioid analgesics in the treatment of pain are offering significant potential for market growth. Misuse of prescription drugs like oxycodone and fentanyl, as well as opioid addiction, are significant global issues that have a detrimental impact on people’s health as well as their economic and social well-being. The Massachusetts Department of Public Health expects that there were 46 to 48 deaths in 2022, bringing the total number of verified and anticipated opioid-related overdose deaths to around 2,357. In 2022, there were 2,310 confirmed opioid-related deaths, according to DPH data. Medical device producers are focusing their efforts and research on creating viable non-opioid alternatives in response to this crisis.
Neuromuscular Pain Attained Revenue of US$ 1,911.9 Million in the Global Market
The neuromuscular pain subsegment dominated the non-opioid pain treatment device market. The segment contributed US$ 1,911.9 million in sales alone in 2022, which is close to 38%.
This prevalence can be due to an increase in jobs that require prolonged sitting and a more sedentary lifestyle, both of which have led to a rise in occurrences of chronic back pain. For instance, 64% of workers polled in Godrej Interio’s Workplace and Ergonomics Research Cell’s “It’s Time to Switch” research sat at their workstations for more than nine hours each day. Long hours of sitting can put a strain on the body and cause serious musculoskeletal problems, which may be the cause of back pain.
For instance, the World Health Organization estimates that 60 to 70 percent of adults in affluent countries have felt low back pain. The American Chiropractic Association, which asserts that back pain is the primary cause of disability and prevents many people from working or engaging in other normal activities, brings attention to this issue further.
Additionally, a rise in the number of prediabetics supports this tendency. According to the National Center for Chronic Disease Prevention and Health Promotion, 38% of adults in the United States who are 18 years of age and older—or about 96 million people—have prediabetes. With these figures, it is anticipated that the market will be significantly impacted in the near future by the rise of the diabetic neuropathy pain category.
North America Contributed Over 35% to the Global Market Revenue Share
North America led the non-opioid pain treatment device market in 2022, with sales there totaling over US$ 1,898.9 million, or around 35% of total sales.
North America is predicted to maintain its dominance in this market as a result of the growing incidence of pain in the region as well, and product launches by the region’s top industry players are anticipated to fuel market expansion over the forecast year.
Chronic pain is one of the key factors driving the market’s rise. According to a study titled “Prevalence of Pain Management Techniques Among Adults with chronic pain in the United States, 2019,” which was published in the JAMA Network in February 2022, one in five people in the United States are believed to have chronic pain. Additionally, the Centers for Disease Control and Prevention estimates that in 2021, there will be 51.6 million adults in the United States who will have chronic pain, and there will be 17.1 million who will have high-impact chronic pain.
Get a Free Sample Report Here- https://www.astuteanalytica.com/industry-report/non-opioid-pain-relief-device-market
Given the emergence of non-opioid replacements, more government inspection of the North American countries in relation to the opioid epidemic is anticipated to be advantageous. The market is expected to grow as a consequence of the increased demand for quick and effective treatment options.
List of Prominent Players
- Abbott Laboratories
- Bayer AG
- Bioelectronics Corporation
- Boston Scientific Corporation
- Medtronic plc
- Koninklijke Philips N.V.
- Neurometrix Inc.
- Nuvectra Corporation
- Omron Corporation
- Stryker Corporation
- SPR Therapeutics, LLC
- Stimwave LLC
- Thermotek Inc.
- Zynex Medical
- Other Prominent Players
Segmentation Outline
The global non-opioid pain relief device market segmentation focuses on Application, Technology, End User, and Region.
By Application
- Neuromuscular
- Musculoskeletal
- Injuries
- Diabetic Neuropathy
- Others
By Technology
- Electroanalgesia
- Implantable Device
- Non-Implantable Device
-
- Traditional TENS
- Wearable TENS
- Others
-
- Radiofrequency Ablation
- Other Emerging Technologies
By End User
- Pain Management Centers
- Hospitals
- Homecare
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Western Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
- South America
- Argentina
- Brazil
- Rest of South America
Get a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/non-opioid-pain-relief-device-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬
𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +𝟏𝟖𝟖𝟖𝟒𝟐𝟗𝟔𝟕𝟓𝟕
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/